Federal drug safety regulators have recommended pausing the use of Johnson & Johnson’s COVID-19 vaccine after six women experienced blood clots after vaccination.
Federal drug safety regulators have recommended pausing the use of Johnson & Johnson’s COVID-19 vaccine after six women experienced blood clots after vaccination.
The COVID-19 pandemic may be the public health crisis on the tips of everyone’s tongues and thumbs.